Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Sierra OncologyAerpio PharmaceuticalsProvectus BiopharmaceuticalsCassava SciencesQ BioMed
SymbolNASDAQ:SRRAOTCMKTS:ARPOOTCMKTS:PVCTNASDAQ:SAVAOTCMKTS:QBIO
Price Information
Current Price$0.36$0.56$0.06$1.88$1.45
52 Week RangeBuyHoldN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyHoldN/ABuyBuy
Consensus Price Target$1.20$4.50N/A$4.50N/A
% Upside from Price Target238.03% upside703.57% upsideN/A139.36% upsideN/A
Trade Information
Market Cap$27.71 million$23.24 million$24.64 million$29.27 million$27.90 million
Beta1.3N/A0.81.855.31
Average Volume858,662247,778234,944394,51689,991
Sales & Book Value
Annual RevenueN/AN/AN/AN/AN/A
Price / SalesN/AN/AN/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$1.27 per shareN/A($0.05) per share$1.14 per share($0.01) per share
Price / BookN/AN/AN/AN/AN/A
Profitability
Net Income$-53,330,000.00N/A$-8,150,000.00$-6,560,000.00$-9,270,000.00
EPS($0.75)N/AN/A($0.61)($0.67)
Trailing P/E RatioN/A0.000.00N/AN/A
Forward P/E RatioN/A1.98N/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)-71.69%N/AN/A-20.65%N/A
Return on Assets (ROA)-60.87%N/A-303.35%-19.74%-611.51%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.07%N/AN/AN/AN/A
Current Ratio7.69%N/A0.38%20.05%0.12%
Quick Ratio7.69%N/A0.38%20.05%0.12%
Ownership Information
Institutional Ownership Percentage51.77%0.37%0.03%10.60%0.05%
Insider Ownership Percentage5.61%38.60%4.50%14.90%N/A
Miscellaneous
Employees79N/A291
Shares Outstanding74.69 million40.59 million389.89 million17.22 million19.24 million
Next Earnings Date2/27/2020 (Estimated)N/A3/5/2020 (Estimated)3/23/2020 (Estimated)3/5/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel